BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30355356)

  • 1. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
    Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
    BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study.
    Muhumuza S; Akello E; Kyomugisha-Nuwagaba C; Baryamutuma R; Sebuliba I; Lutalo IM; Kansiime E; Kisaakye LN; Kiragga AN; King R; Bazeyo W; Lindan C
    PLoS One; 2017; 12(12):e0187605. PubMed ID: 29272268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART.
    Nuwagaba-Biribonwoha H; Kiragga AN; Yiannoutsos CT; Musick BS; Wools-Kaloustian KK; Ayaya S; Wolf H; Lugina E; Ssali J; Abrams EJ; Elul B;
    J Int AIDS Soc; 2018 Sep; 21(9):e25178. PubMed ID: 30225908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing postnatal Option B+ participation and breastfeeding duration among HIV-positive women in Lilongwe District, Malawi: A qualitative study.
    Flax VL; Hamela G; Mofolo I; Hosseinipour MC; Hoffman IF; Maman S
    PLoS One; 2017; 12(4):e0175590. PubMed ID: 28410374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why did I stop? And why did I restart? Perspectives of women lost to follow-up in option B+ HIV care in Dar es Salaam, Tanzania.
    Sariah A; Rugemalila J; Protas J; Aris E; Siril H; Tarimo E; Urassa D
    BMC Public Health; 2019 Aug; 19(1):1172. PubMed ID: 31455306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with retention of mother-baby pairs in the elimination of mother-to-child transmission of HIV program in Kaberamaido district: A longitudinal analysis.
    Odongo JD; Opito R; Wanume B; Bwayo D; Mukunya D; Okware S; Matovu JKB
    PLoS One; 2023; 18(7):e0288562. PubMed ID: 37478084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.
    Hibstie YT; Kibret GD; Talie A; Temesgen B; Melkamu MW; Alebel A
    PLoS One; 2020; 15(9):e0239013. PubMed ID: 32931502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study.
    Kyaw KWY; Oo MM; Kyaw NTT; Phyo KH; Aung TK; Mya T; Aung N; Oo HN; Isaakidis P
    PLoS One; 2017; 12(9):e0184426. PubMed ID: 28886165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and Predictors of HIV-Exposed Infants Lost to Follow-Up During Early Infant Diagnosis Services in Kenya.
    Goggin K; Hurley EA; Staggs VS; Wexler C; Nazir N; Gautney B; Khamadi SA; Maloba M; Lwembe R; Finocchario-Kessler S
    AIDS Patient Care STDS; 2019 Aug; 33(8):346-353. PubMed ID: 31369296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention in Care among HIV-Infected Adults in Ethiopia, 2005- 2011: A Mixed-Methods Study.
    Tiruneh YM; Galárraga O; Genberg B; Wilson IB
    PLoS One; 2016; 11(6):e0156619. PubMed ID: 27272890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
    Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
    Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.